Aurigene Discovery Technologies Limited based in Bangalore, India is a partnership-focused collaborative Discovery organization.
Aurigene is set up on a 17-acre campus, with a built-up area of 220,000 sq.ft. Aurigene has a world class, integrated infrastructure for Drug Discovery, starting from protein expression and purification, all the way through Medicinal Chemistry and Pre-clinical Biology. Aurigene's particular strengths are in SBDD with in-house X-Ray, Bio NMR and Computational capabilities.
High quality scientific manpower with experience in their respective areas as well as an overall understanding of the integrated Drug Discovery process enhance Aurigene's state-of-the-art infrastructure.
Aurigene is an independent subsidiary of Dr Reddy's Laboratories Limited (DRL). DRL is listed both on the New York Stock Exchange (NYSE) and on the Bombay Stock Exchange (BSE) with significant operations in the USA and Europe.